SKIN Share Price Performance
US$1.46
-0.09 (-5.81%)
24.5% undervalued intrinsic discount
US$1.93
Fair Value
Price US$1.46
AnalystConsensusTarget US$1.93
AnalystHighTarget US$3.38
AnalystLowTarget US$1.50
Fair ValueUS$1.93
Share Pricen/a
The Beauty Health Company Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
SKIN Community Narratives
AN
Fair Value US$1.93 24.5% undervalued intrinsic discount
Premium Beauty Markets Will Face Risks And Rewards
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value US$3.38 56.8% undervalued intrinsic discount
Rising Self-Care And Telehealth Trends Will Power Global Expansion
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value US$1.5 2.7% undervalued intrinsic discount
Less Invasive Aesthetic Demand Will Support Consumables While Device Weakness Keeps Expectations Grounded
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Rising Self-Care And Telehealth Trends Will Power Global Expansion
Key Takeaways Breakthrough product launches, provider-focused innovation, and loyalty programs are positioned to drive recurring high-margin sales and expand market reach amid a shift to non-invasive self-care. Streamlined operations, centralized manufacturing, and adoption of digital channels could boost profitability, customer retention, and accelerate efficient global expansion beyond current analyst expectations.Read more
17
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$3.38
56.8% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
3.14% p.a.
Profit Margin
5.46%
Future PE
34.85x
Price in 2028
US$4.68
Less Invasive Aesthetic Demand Will Support Consumables While Device Weakness Keeps Expectations Grounded
Catalysts About Beauty Health The Beauty Health Company develops and commercializes Hydrafacial devices and high margin consumable boosters used in professional skin health treatments worldwide. What are the underlying business or industry changes driving this perspective?Read more
0
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$1.5
2.7% undervalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
2.49% p.a.
Profit Margin
5.46%
Future PE
15.93x
Price in 2028
US$2.1
Premium Beauty Markets Will Face Risks And Rewards
Key Takeaways Overreliance on premium offerings and Hydrafacial leaves the company vulnerable to shifting consumer trends, economic pressures, and evolving competitive dynamics. Rising regulatory and sustainability demands may increase costs and suppress margins, hampering long-term revenue and earnings growth.Read more
41
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
US$1.93
24.5% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
4.01% p.a.
Profit Margin
5.46%
Future PE
19.56x
Price in 2028
US$2.69
Trending Discussion
Recently Updated Narratives
AN
SKIN: Share Repurchase And New CEO Are Expected To Drive Upside
Fair Value: US$3.38 56.8% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Less Invasive Aesthetic Demand Will Support Consumables While Device Weakness Keeps Expectations Grounded
Fair Value: US$1.5 2.7% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
SKIN: Future Returns Will Be Driven By Improved Device Churn Management
Fair Value: US$1.93 24.5% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
The Beauty Health Company Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -0.092
- 64.81%
- -3.89%
- 553.4%
About SKIN
- Founded
- 1997
- Employees
- 769
- CEO
- WebsiteView website
The Beauty Health Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells esthetic technologies and products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company’s flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer’s preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers. The Beauty Health Company was founded in 1997 and is headquartered in Long Beach, California.
